Medtech

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

January 6, 2025

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

December 18, 2024

Tasca Therapeutics Launches with $52 Million Series A Financing

December 10, 2024

THIS WEEK'S STORIES

Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer

January 6, 2025

Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer

January 7, 2025

athenahealth Names New Executives to Drive Clinician-Centered Innovation, Advance the Company’s Strategic Focus on Ambulatory Care

January 6, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Royal Orthopaedic Hospital Leverages VitVio’s AI-powered Platform to Increase the Efficiency and Safety in Operating Rooms

CardioFocus Announces First Patients Treated with OptiShot™ Pulsed Field Ablation System

RevBio Receives Both FDA Approval to Expand its Clinical Trial and CMS Reimbursement for its Regenerative Bone Adhesive for Cranial Flap Fixation

FDA Grants Breakthrough Device Designation to MeMed Severity Test for Patients with Suspected Sepsis

DocGo Signs Contract in Mississippi with Major Hospital System to Provide Adult and Pediatric Remote Cardiac Monitoring Services

Most Read

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Transcarent To Acquire Accolade

Odyssey Therapeutics Appoints Jason Haas as Chief Financial Officer

Royal Orthopaedic Hospital Leverages VitVio’s AI-powered Platform to Increase the Efficiency and Safety in Operating Rooms

EDITOR PICKS

TreeFrog Therapeutics Leases 13,488 Square Feet at Cambridgeport Labs

MilliporeSigma to Acquire HUB Organoids Holding B.V., Advancing Next Generation Biology Portfolio

Tasca Therapeutics Launches with $52 Million Series A Financing

THIS WEEK'S STORIES

Iambic Therapeutics Appoints Michael Secora, Ph.D. as Chief Corporate Development Officer and Chief Financial Officer

Aro Biotherapeutics Appoints Glenn Crater, MD, as Chief Medical Officer

athenahealth Names New Executives to Drive Clinician-Centered Innovation, Advance the Company’s Strategic Focus on Ambulatory Care

POPULAR CATEGORY

ABOUT US

FOLLOW US